5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

BACKGROUND and AIMS: This study was performed to quantify the risk of renal disease in patients using aminosalicylates (5-ASA). METHODS: Data from the United Kingdom General Practice Research Database were used to estimate the incidence of renal disease in adult patients with inflammatory bowel dis...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Van Staa, T, Travis, S, Leufkens, H, Logan, R
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2004

Antzeko izenburuak

Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid
nork: Harshna Patel, et al.
Argitaratua: (2009-01-01)

Sonoelectrochemically enhanced determination of 5-aminosalicylic acid.
nork: Beckett, E, et al.
Argitaratua: (2001)

Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
nork: M. Campieri, et al.
Argitaratua: (1989-01-01)

Mechanism of action of 5-aminosalicylic acid and its derivatives.
nork: Ireland, A, et al.
Argitaratua: (1990)

Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)
nork: Robert D. Crapnell, et al.
Argitaratua: (2023-12-01)

Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
nork: Andrew W Kirkpatrick, et al.
Argitaratua: (1999-01-01)

Pharmacokinetics of 5-Aminosalicylic Acid Enteral Suspension in Crohn's Disease Patients and Normal Volunteers
nork: CN Williams, et al.
Argitaratua: (1990-01-01)

Aminosalicylates in inflammatory bowel disease
nork: Vojislav N. Perisic
Argitaratua: (2013-10-01)

Controlled Release of 5-Aminosalicylic Acid (5-ASA) from New Biodegradable Polyurethanes
nork: El-Refaie Kenawy, et al.
Argitaratua: (2010-03-01)

Does a fracture at one site predict later fractures at other sites? A British cohort study.
nork: van Staa, T, et al.
Argitaratua: (2002)

Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells.
nork: Ireland, A, et al.
Argitaratua: (1990)

Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
nork: MG Robinson, et al.
Argitaratua: (1990-01-01)

Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps
nork: Tina Kirchner, et al.
Argitaratua: (2013-01-01)

Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
nork: Hye Young Lee, et al.
Argitaratua: (2024-05-01)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
nork: Long He, et al.
Argitaratua: (2021-05-01)

5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
nork: Hans Herfarth, et al.
Argitaratua: (2021-09-01)

Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid
nork: Ashok K. Batta, et al.
Argitaratua: (1998-08-01)

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
nork: van Staa, T, et al.
Argitaratua: (2002)

Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid.
nork: Ireland, A, et al.
Argitaratua: (1988)

5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and Proctitis
nork: Lloyd R Sutherland, et al.
Argitaratua: (1987-01-01)

Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy
nork: Bharat Kumar Reddy Sanapalli, et al.
Argitaratua: (2024-08-01)

5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
nork: Jihee Kim, et al.
Argitaratua: (2024-02-01)

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
nork: Aziz Şener, et al.
Argitaratua: (2018-09-01)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
nork: M. V. Shapina, et al.
Argitaratua: (2017-11-01)

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
nork: Hyo Yeop Song, et al.
Argitaratua: (2022-01-01)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
nork: Yan Yan, et al.
Argitaratua: (2019-12-01)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
nork: Jun Xu, et al.
Argitaratua: (2018-06-01)

Epidemiology of fractures in England and Wales.
nork: van Staa, T, et al.
Argitaratua: (2001)

The epidemiology of fractures in England and Wales
nork: van Staa, T, et al.
Argitaratua: (2001)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
nork: Ajit Sood, et al.
Argitaratua: (2020-10-01)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
nork: Cristiana Perrotta, et al.
Argitaratua: (2015-01-01)

Effect of High Dose Aminosalicylic Acid on Gastroduodenal Mucosa
nork: DJ Leddin, et al.
Argitaratua: (1993-01-01)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
nork: Shinta Mizuno, et al.
Argitaratua: (2020-01-01)

5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon.
nork: Paolo, D, et al.
Argitaratua: (1996)

Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
nork: Hiroshi Matsumoto, et al.
Argitaratua: (2024-09-01)

Prevention of Relapse in Ulcerative Colitis Using Oral or Topical 5-Aminosalicylic Acid Therapy
nork: Lloyd R Sutherland
Argitaratua: (1993-01-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
nork: Soo-Kyung Park, et al.
Argitaratua: (2022-09-01)

Preparation and in-vitro characterization of 5-aminosalicylic acid loaded hydrogels for colon specific delivery
nork: Muhammad Suhail, et al.
Argitaratua: (2022-11-01)

Synthesis, characterization and radical scavenging activity of aromatic amine conjugates of 5-aminosalicylic acid
nork: K. Harveer,, et al.
Argitaratua: (2014-09-01)

Preparation and evaluation of magnetic microspheres of mesalamine (5-aminosalicylic acid) for colon drug delivery
nork: Satinder Kakar, et al.
Argitaratua: (2013-01-01)